BillionToOne, Inc.
BLLN
주식 순위
#3445
BillionToOne, Inc. is a specialized diagnostics company that innovates by... BillionToOne, Inc. is a specialized diagnostics company that innovates by precisely quantifying biological data to create advanced molecular diagnostic solutions. Central to their operations is a cutting-edge molecular counting platform, meticulously engineered to identify and measure individual DNA molecules, thereby significantly enhancing the precision of disease detection. Their product portfolio includes: UNITY Complete: A non-invasive prenatal screen that assesses a fetus's risk for aneuploidies, recessive genetic conditions, and fetal antigens, all from a simple maternal blood sample. Northstar Select: A liquid biopsy test designed to pinpoint specific mutations present in tumors, encompassing deletions, insertions, and point mutations. Northstar Response: A diagnostic tool that enables continuous tracking of cancer progression through detailed methylation assessment. Established in 2016, BillionToOne, Inc. conducts its operations from its headquarters located in Menlo Park, California.
주가
$105.11
마지막 동기화: 2026-10-21
시가총액
$4.96B
변동 (1일)
1.56%
변동 (1년)
-
국가
US
거래 BillionToOne, Inc. (BLLN)
카테고리
Healthcare
BillionToOne, Inc. (BLLN)의 주가 이력
최고 종가: $100.39 (2026-10-01 기준)
최저 종가: $106.24 (2025-11-01 기준)
최저 종가: $106.24 (2025-11-01 기준)
BillionToOne, Inc.의 주가 이력 (2025 ~ 2026)
연간 주가 성과
| 연도 | 성과 |
|---|---|
| 2026 (TTM) | -1.87% |
| 2025 | 0.00% |
유사 기업 또는 경쟁사의 주가
| 회사 | 주가 | 변동률 1년% | 국가 |
|---|---|---|---|
| $694.53 | 22.45% |
US
|
|
| $234.00 | 7.29% |
US
|
|
| $416.01 | 121.26% |
US
|
|
| $21.05 | 48.68% |
CN
|
|
| $177.93 | 21.98% |
US
|
